v3.25.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss), Net
Accumulated Deficit
Parent
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2021   2,027,474,000          
Beginning balance at Dec. 31, 2021 $ 2,291,030 $ 2,027 $ 7,777,085 $ (2,349) $ (5,485,733) $ 2,291,030 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from the exercise of stock options (in shares)   19,660,000          
Issuance of common stock from the exercise of stock options 86,088 $ 20 86,068     86,088  
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)   51,941,000          
Issuance of common stock upon vesting of restricted stock units (“RSUs”)   $ 52 (52)        
Stock-based compensation 564,897   564,897     564,897  
Other comprehensive income (loss) (2,984)     (2,984)   (2,984)  
Other, net 74,500           74,500
Net income (loss) (371,094)       (373,705) (373,705) 2,611
Ending balance (in shares) at Dec. 31, 2022   2,099,075,000          
Ending balance at Dec. 31, 2022 2,642,437 $ 2,099 8,427,998 (5,333) (5,859,438) 2,565,326 77,111
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from the exercise of stock options (in shares)   46,079,000          
Issuance of common stock from the exercise of stock options 218,238 $ 46 218,192     218,238  
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)   54,974,000          
Issuance of common stock upon vesting of restricted stock units (“RSUs”)   $ 55 (55)        
Stock-based compensation 476,038   476,038     476,038  
Other comprehensive income (loss) 6,134     6,134   6,134  
Other, net 743           743
Net income (loss) $ 217,375       209,825 209,825 7,550
Ending balance (in shares) at Dec. 31, 2023 2,200,128,000 2,200,128,000          
Ending balance at Dec. 31, 2023 $ 3,560,965 $ 2,200 9,122,173 801 (5,649,613) 3,475,561 85,404
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from the exercise of stock options (in shares) 99,297,000 99,297,000          
Issuance of common stock from the exercise of stock options $ 745,396 $ 100 745,296     745,396  
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares)   35,550,000          
Issuance of common stock upon vesting of restricted stock units (“RSUs”)   $ 35 (35)        
Repurchases of common stock (in shares)   (2,123,000)          
Repurchases of common stock (64,196) $ (2) (64,194)     (64,196)  
Stock-based compensation 693,223   693,223     693,223  
Other comprehensive income (loss) (6,412)     (6,412)   (6,412)  
Net income (loss) $ 467,918       462,190 462,190 5,728
Ending balance (in shares) at Dec. 31, 2024 2,338,795,000 2,338,795,000          
Ending balance at Dec. 31, 2024 $ 5,094,407 $ 2,339 10,193,970 $ (5,611) $ (5,187,423) 5,003,275 $ 91,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock Issued During Period, Shares, Stock Appreciation Rights, Net of Shares Withheld for Employee Taxes   5,943,000          
Stock Issued During Period, Value, Stock Appreciation Rights, Net of Shares Withheld for Employee Taxes $ (302,487) $ 6 $ (302,493)     $ (302,487)